Related Experiment Videos

Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human

Kenji Matsumoto1, Yukihiro Akao, Emi Kobayashi

  • 1Gifu International Institute of Biotechnology, Kani-Gun, Gifu, Japan.

Biological & Pharmaceutical Bulletin
|April 4, 2003
PubMed

Insights

Garcinol, isogarcinol, and xanthochymol suppress leukemia cell growth by inducing apoptosis via caspase-3 activation. Isogarcinol and xanthochymol show greater potency than garcinol.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Benzophenone derivatives are known for their cytotoxic properties.
  • Leukemia remains a significant hematological malignancy requiring novel therapeutic agents.

Purpose of the Study:

  • To investigate the in vitro anti-leukemic effects of garcinol, isogarcinol, and xanthochymol.
  • To elucidate the mechanisms underlying their cytotoxic activity in human leukemia cell lines.

Main Methods:

  • Treatment of four human leukemia cell lines with garcinol, isogarcinol, and xanthochymol.
  • Assessment of cell growth inhibition, apoptosis induction, and caspase-3 activation.
  • Evaluation of mitochondrial membrane potential changes.

Main Results:

  • All tested compounds significantly inhibited leukemia cell growth.
  • Apoptosis was induced by all compounds, mediated by caspase-3 activation.
  • Garcinol and isogarcinol induced loss of mitochondrial membrane potential, unlike xanthochymol.
  • Isogarcinol and xanthochymol demonstrated more potent growth inhibitory effects compared to garcinol.

Conclusions:

  • Garcinol, isogarcinol, and xanthochymol possess significant in vitro anti-leukemic activity.
  • The compounds induce apoptosis through caspase-3 activation, with varying effects on mitochondrial potential.
  • Isogarcinol and xanthochymol represent promising candidates for further leukemia therapeutic research.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...